These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7940864)
1. Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Transplant Proc; 1994 Oct; 26(5):2749. PubMed ID: 7940864 [No Abstract] [Full Text] [Related]
2. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [TBL] [Abstract][Full Text] [Related]
3. Follow-up after conversion to Neoral in stable heart transplant recipients. Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226 [No Abstract] [Full Text] [Related]
4. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
5. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation. Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219 [No Abstract] [Full Text] [Related]
6. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation. Jennison SH; Wesp AG; McBride LR; Miller LW Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857 [No Abstract] [Full Text] [Related]
7. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation. Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613 [TBL] [Abstract][Full Text] [Related]
8. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients. Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225 [No Abstract] [Full Text] [Related]
9. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
10. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients. Cantarovich M; Besner JG; Fitchett DH; Latter DA Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930 [TBL] [Abstract][Full Text] [Related]
11. Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients. Mamprin F; Gamba A; Fiocchi R; Merlo M; Senni M; Troise G; Binetti G; Motta T; Parma A; Ferrazzi P Transplant Proc; 1994 Oct; 26(5):2581-2. PubMed ID: 7940800 [No Abstract] [Full Text] [Related]
12. Impact of cyclosporine dose on long-term outcome after heart transplantation. Valantine H; Hunt S; Gamberg P; Miller J; Luikart H Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848 [No Abstract] [Full Text] [Related]
13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352 [TBL] [Abstract][Full Text] [Related]
16. Late acute cardiac allograft rejection: new therapeutic options? Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
18. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction]. Mota A Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737 [TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869 [TBL] [Abstract][Full Text] [Related]